Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery (RegistStents)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01171612 |
|
Recruitment Status :
Completed
First Posted : July 28, 2010
Results First Posted : November 25, 2013
Last Update Posted : April 7, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
The purpose of this study is to evaluate and monitor perioperative management of patients with coronary stents undergoing noncardiac surgery.
Objectives:
- To describe the incidence and severity of adverse cardiovascular events in patients with coronary stents undergoing noncardiac surgery with admission.
- To assess the following-up of the guidelines about the perioperative management of antiplatelet therapy in these patients.
- To assess the relationship between the incidence of cardiac or neurovascular events, as well as bleeding complications with the perioperative management of antiplatelet therapy.
- Number of Participants with Adverse Events as a Measure of Safety
| Condition or disease |
|---|
| Acute Coronary Syndrome Coronary Stent Occlusion Surgery |
| Study Type : | Observational |
| Actual Enrollment : | 483 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Evaluation and Monitoring of Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery |
| Study Start Date : | June 2009 |
| Actual Primary Completion Date : | February 2010 |
| Actual Study Completion Date : | July 2012 |
| Group/Cohort |
|---|
|
Coronary Stent
Patients with coronary Bare Metal Stent (BMS) or Drug Eluting Stent (DES) undergoing noncardiac surgery
|
- Major Adverse Cardiac and Cerebrovascular Events (MACCEs) [ Time Frame: up to 90 days after surgery ]Cardiac Mortality, Myocardial Infarction, Angina Pectoris, new arrythmia, Congestive Heart Failure, Stroke, Cardiac Arrest
- Major Haemorrhagic Events [ Time Frame: up to 90 days after surgery ]Transfusion > = 2 red blood cells Units, haemoglobin descent >= 20 gr/dL, intracerebral haemorrhage
- Number of Patients With Adverse Events Related With Antiplatelet Therapy Management [ Time Frame: 90 days after surgery ]
Perioperative withdrawal antiplatelet therapy is defined with > or = 5 days without therapy
We create 3 categories:
- Not withdrawal
- Complete withdrawal (5 or > days without antiplatelet drugs , mono or dual therapy)
- Incomplete withdrawal: patients under dual antiplatelet therapy, who maintain aspirin and stopped clopidogrel =/ > 5 days
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- > 18 years old, with coronary stents
- American Society of Anaesthesia physical status II-V
- noncardiac surgery wiht admission
- informed consent
Exclusion Criteria:
- < 18 years old
- American Society of Anaesthesia physical status I
- ambulatory surgery
- pregnancy
- obstetric anaesthesia
- endoscopic procedures
- cardiac surgery
- not informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01171612
| Spain | |
| Hospital Germans Trias i Pujol | |
| Badalona, Barcelona, Spain | |
| Hospital Municipal de Badalona | |
| Badalona, Barcelona, Spain | |
| Hospital Igualada | |
| Igualada, Barcelona, Spain | |
| Hospital de Mataró | |
| Mataró, Barcelona, Spain | |
| Hospital de Sabadell. Corporació Sanitària Parc Taulí | |
| Sabadell, Barcelona, Spain, 08208 | |
| Hospital de Sant Celoni | |
| Sant Celoni, Barcelona, Spain | |
| Clínica ASEPEYO | |
| Sant Cugat del Valles, Barcelona, Spain | |
| Hospital Sant Joan Despi Moisès Broggi | |
| Sant Joan Despi, Barcelona, Spain | |
| Hospital Mútua de Terrassa | |
| Terrassa, Barcelona, Spain, 08221 | |
| Fundació Puigvert - IUNA | |
| Barcelona, Spain | |
| Hospital Clínic | |
| Barcelona, Spain | |
| Parc de Salut Mar-Esperança | |
| Barcelona, Spain | |
| Parc de Salut Mar | |
| Barcelona, Spain | |
| Principal Investigator: | Anna Rodriguez-Pont, MD | Corporacio Sanitaria Parc Tauli |
| Responsible Party: | Anna Rodriguez Pont, MD, Corporacion Parc Tauli |
| ClinicalTrials.gov Identifier: | NCT01171612 |
| Other Study ID Numbers: |
CIR2009017 |
| First Posted: | July 28, 2010 Key Record Dates |
| Results First Posted: | November 25, 2013 |
| Last Update Posted: | April 7, 2016 |
| Last Verified: | March 2016 |
|
Coronary Stent BMS stent DES stent Date of stent implantation |
cardiac event neurovascular event Bleeding transfusion |
|
Acute Coronary Syndrome Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |

